Healthcare provider profile · identity verified

Sunitha Potluri, MD

Internal Medicine · ALLENTOWN, PA · NPI 1437321353

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	464	54
Furosemide	Furosemide	423	53
Atorvastatin Calcium	Atorvastatin Calcium	379	65
Eliquis	Apixaban	346	41
Gabapentin	Gabapentin	328	60
Metoprolol Succinate	Metoprolol Succinate	196	33
Potassium Chloride	Potassium Chloride	187	33
Lisinopril	Lisinopril	184	32
Pantoprazole Sodium	Pantoprazole Sodium	181	32
Tamsulosin Hcl	Tamsulosin Hcl	168	30
Buspirone Hcl	Buspirone Hcl	166	27
Sertraline Hcl	Sertraline Hcl	161	26
Metoprolol Tartrate	Metoprolol Tartrate	152	43
Amlodipine Besylate	Amlodipine Besylate	150	28
Simvastatin	Simvastatin	144	24
Baclofen	Baclofen	136	18
Clopidogrel	Clopidogrel Bisulfate	115	19
Divalproex Sodium	Divalproex Sodium	105	18
Mirtazapine	Mirtazapine	105	24
Trazodone Hcl	Trazodone Hcl	103	24
Metformin Hcl	Metformin Hcl	101	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	16
Quetiapine Fumarate	Quetiapine Fumarate	90	15
Escitalopram Oxalate	Escitalopram Oxalate	83	21
Famotidine	Famotidine	82	19
Hydrochlorothiazide	Hydrochlorothiazide	78	suppressed
Montelukast Sodium	Montelukast Sodium	78	11
Omeprazole	Omeprazole	77	18
Spironolactone	Spironolactone	77	17
Januvia	Sitagliptin Phosphate	72	suppressed
Finasteride	Finasteride	68	12
Oxycodone Hcl	Oxycodone Hcl	67	22
Duloxetine Hcl	Duloxetine Hcl	64	12
Levetiracetam	Levetiracetam	59	suppressed
Methocarbamol	Methocarbamol	59	12
Citalopram Hbr	Citalopram Hydrobromide	55	suppressed
Tradjenta	Linagliptin	54	suppressed
Torsemide	Torsemide	53	11
Olanzapine	Olanzapine	52	14
Pravastatin Sodium	Pravastatin Sodium	51	suppressed
Cephalexin	Cephalexin	44	22
Fluticasone Propionate	Fluticasone Propionate	44	16
Lamotrigine	Lamotrigine	44	suppressed
Trulicity	Dulaglutide	44	suppressed
Valsartan	Valsartan	44	suppressed
Ondansetron Hcl	Ondansetron Hcl	43	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Lorazepam	Lorazepam	41	24
Carvedilol	Carvedilol	38	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	38	12
Losartan Potassium	Losartan Potassium	38	13
Repaglinide	Repaglinide	37	suppressed
Nystatin	Nystatin	36	12
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	32	suppressed
Benztropine Mesylate	Benztropine Mesylate	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Latanoprost	Latanoprost	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	11
Clonidine Hcl	Clonidine Hcl	27	suppressed
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Restasis	Cyclosporine	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	14
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	14
Entresto	Sacubitril/Valsartan	25	suppressed
Carbamazepine Er	Carbamazepine	24	suppressed
Memantine Hcl Er	Memantine Hcl	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Risperidone	Risperidone	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	21	suppressed
Lactulose	Lactulose	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Haloperidol	Haloperidol	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Prednisone	Prednisone	18	11
Rasagiline Mesylate	Rasagiline Mesylate	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	12
Clonazepam	Clonazepam	17	suppressed
Clozapine	Clozapine	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Glipizide	Glipizide	17	suppressed
Mupirocin	Mupirocin	17	11
Premarin	Estrogens, Conjugated	17	suppressed
Ursodiol	Ursodiol	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Budesonide	Budesonide	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Digoxin	Digoxin	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Olanzapine Odt	Olanzapine	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Copaxone	Glatiramer Acetate	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Atenolol	Atenolol	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error